Recent progress of migraine and pregnancy
10.3760/cma.j.issn.1008-6315.2017.06.019
- VernacularTitle:偏头痛与妊娠的相关问题及治疗进展
- Author:
Liuqing WANG
;
Xuran XU
;
Shoucheng ZHANG
;
Hong WANG
;
Bei SHAO
- Keywords:
Migraine;
Pregnancy;
Lactating;
Fetus;
Paracetamol
- From:
Clinical Medicine of China
2017;33(6):551-554
- CountryChina
- Language:Chinese
-
Abstract:
As a kind of nervous system disease,migraine is more common in female,and has the clinical characteristics of repeated attacks,it is of great significance with standardized treatment in the control of the attacks.Yong female patients with migraine during pregnancy and lactation stage will face lots of special problems because they must first consider the impact of treatment on the mother and fetus.Generally,non-drug therapy is recommended as a first-line treatment,if it is not sufficiently effective,paracetamol is recommended during the pregnancy or sporadic use of sumatriptan,NSAIDs is not recommended during the first or third trimester of pregnancy.Preventive therapy should only be considered in the most severe cases.This review summarized recent documents of the safety of the most used antimigraine medications during pregnancy and breastfeeding,in order to provide treatment recommendations in clinical practice.
